Literature DB >> 20161237

Unexpected Formation of Highly Functionalized Dihydropyrans via Addition-Cyclization Reactions Between Dimethyl Oxoglutaconate and α,β-Unsaturated Hydrazones.

Jason E Mullins1, Jean-Louis G Etoga, Mariusz Gajewski, Joseph I Degraw, Charles M Thompson.   

Abstract

The condensation between dienophiles and α,β-unsaturated hydrazone azadienes was previously reported to afford piperidines. During an attempt to adapt this reaction to the preparation of piperidine-based conformationally-restricted analogs of glutamate, it was discovered that the electrophile, dimethyl oxoglutaconate (DOG) led to highly substituted dihydropyrans in 20-50% yield. The unexpected pyran product likely results from an initial 1,4-addition of the hydrazone to the oxoglutaconate followed by intramolecular cyclization of the resultant enolate oxygen to the α,β-unsaturated iminium ion. Further manipulations afford substituted tetrahydropyran 6-methamino-2,4-dicarboxylic acids.

Entities:  

Year:  2009        PMID: 20161237      PMCID: PMC2705200          DOI: 10.1016/j.tetlet.2009.02.180

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  9 in total

Review 1.  The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.

Authors:  Richard J Bridges; C Sean Esslinger
Journal:  Pharmacol Ther       Date:  2005-04-14       Impact factor: 12.310

2.  Binding of the radiolabeled glycine site antagonist [3H]MDL 105,519 to homomeric NMDA-NR1a receptors.

Authors:  B W Siegel; K Sreekrishna; B M Baron
Journal:  Eur J Pharmacol       Date:  1996-10-03       Impact factor: 4.432

3.  L-trans-2,3-pyrrolidine dicarboxylate: characterization of a novel excitotoxin.

Authors:  C L Willis; J M Humphrey; H P Koch; J A Hart; T Blakely; L Ralston; C A Baker; S Shim; M Kadri; A R Chamberlin; R J Bridges
Journal:  Neuropharmacology       Date:  1996-05       Impact factor: 5.250

4.  Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer.

Authors:  R J Bridges; M S Stanley; M W Anderson; C W Cotman; A R Chamberlin
Journal:  J Med Chem       Date:  1991-02       Impact factor: 7.446

5.  Specific binding of [3H]kainic acid to receptor sites in rat brain.

Authors:  E D London; J T Coyle
Journal:  Mol Pharmacol       Date:  1979-05       Impact factor: 4.436

6.  Synthesis and preliminary evaluation of trans-3,4-conformationally-restricted glutamate and pyroglutamate analogues as novel EAAT2 inhibitors.

Authors:  Travis Denton; Todd Seib; Richard Bridges; Charles Thompson
Journal:  Bioorg Med Chem Lett       Date:  2002-11-04       Impact factor: 2.823

7.  Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.

Authors:  Christina N Carrigan; Richard D Bartlett; C Sean Esslinger; Kimberly A Cybulski; Pakamas Tongcharoensirikul; Richard J Bridges; Charles M Thompson
Journal:  J Med Chem       Date:  2002-05-23       Impact factor: 7.446

8.  The binding of [3H]AMPA, a structural analogue of glutamic acid, to rat brain membranes.

Authors:  T Honoré; J Lauridsen; P Krogsgaard-Larsen
Journal:  J Neurochem       Date:  1982-01       Impact factor: 5.372

9.  Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex.

Authors:  J L Arriza; W A Fairman; J I Wadiche; G H Murdoch; M P Kavanaugh; S G Amara
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.